Moreover, its expression also exhibits prognostic significance in multiple myeloma, enabling the better risk stratification of stage II myeloma patients [23], underscoring the translational value of circ-CCT3 for precision oncology in solid and hematological malignancies. This evidence concerns the gene CCT3 and plasma cell myeloma.